Literature DB >> 32413527

COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Barbara Alicja Jereczek-Fossa1, Matteo Pepa2, Giulia Marvaso3, Alessio Bruni4, Michela Buglione di Monale E Bastia5, Gianpiero Catalano6, Andrea Riccardo Filippi7, Pierfrancesco Franco8, Maria Antonietta Gambacorta9, Domenico Genovesi10, Giuseppe Iatì11, Alessandro Magli12, Luigi Marafioti13, Icro Meattini14, Anna Merlotti15, Marcello Mignogna16, Daniela Musio17, Roberto Pacelli18, Stefano Pergolizzi11, Vincenzo Tombolini17, Marco Trovò12, Umberto Ricardi8, Stefano Maria Magrini5, Renzo Corvò19, Vittorio Donato20.   

Abstract

Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AIRO (Italian Association of Radiotherapy and Clinical Oncology); COVID-19; Italy; Radiation oncology; Survey

Mesh:

Year:  2020        PMID: 32413527      PMCID: PMC7215158          DOI: 10.1016/j.radonc.2020.04.061

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


Since 20th February 2020, Italy has been experiencing one of the deadliest COVID-19 outbreaks in the world, with 197,675 people tested positive as of 27th April 2020 and 26,644 deaths occurring in two months [1]. The whole country was put in total lockdown since the 9th of March 2020 and only essential services were permitted (the citizens were allowed to go out only for essential job or healthy issues). The Italian healthcare system has been overwhelmed by the emergency, and so did the radiation therapy (RT) facilities. Considering that RT treatments are indicated in about 50% of cancer patients [2], Italian Radiation Oncology Departments had to fully reorganise their activity trying to find a hypothetical trade-off between the risk of cancer progression in case of RT interruption and the likelihood of SARS-CoV-2 infection in case of RT initiation or continuation. Although cancer patients are frequently frail and immunocompromised [3], RT is a life-saving treatment and should not be delayed or interrupted if possible [4]. Since the beginning of the COVID-19 outbreak in Italy, the Italian Association of Radiotherapy and Clinical Oncology (AIRO) has put any effort to produce and continuously update a guidance document with detailed instructions for Italian radiation oncologists on how to rapidly and safely cope with the ongoing pandemic [5]. The present study, based on a digital survey administered to the Directors of the Italian Radiation Oncology Departments through the AIRO mailing list, is aimed at identifying the strategies that the Italian RT facilities have implemented to face this unprecedented emergency. The present investigation, performed on a national basis, was preceded by a similar survey conducted in Lombardy, the Italian region in which the pandemic has most massively spread, accounting for approximately half of all Italian cases and deaths [6]. Therefore, national and Lombardy survey results will be also compared.

Materials and methods

An online questionnaire (32 multiple-choice questions) via Google Forms, based on the first COVID-19 reports [7], [8], [9], [10], [11], and on the former investigation carried out in Lombardy [6], was administered to the 176 Directors of Italian Radiation Oncology Departments, members of the AIRO, between the 6th and 16th April 2020. The questionnaire included general queries and sections dedicated to clinical and out-patient activities, patients and staff management (text of survey available in Supplementary Materials). For some questions, more than one answer were allowed. Figures have been created using Microsoft Excel Bing Maps, Bing © GeoNames, HERE, MSFT.

Results

Out of the 176 contacted Directors of the Italian RT facilities, 125 (71%) anonymously responded to the survey.

General information

Responding centres were equally divided into public facilities and university or private hospitals. Twenty per cent of responders worked in Lombardy, the most populated Italian region (10 out of 60 million Italians live in Lombardy). Regarding the dimension of the centres, 79 (63.2%) treat less than 1000 patients/year, 34 (27.2%) between 1000 and 2000 and the remaining 12 (9.6%) more than 2000. Approximately 80% of RT facilities are active in hospitals equipped with an emergency department. Within few weeks from the outbreak, 85 structures (68%) became COVID-19 centres, requiring immediate reorganisation of the entire facility. Few Radiation Oncology Departments (less than 15%) had in-patients and/or day hospital wards, which were converted into COVID-19 wards in less than half of the cases.

Management of clinical and outpatient activities

The management of the emergency was mainly (88.8%) coordinated by the Director of the department, but the Health Directorate was also involved in 46 (36.8%) centres. In the difficult quest for a compromise between necessity of RT treatments and risk of infection, most centres were compelled to reorganise their therapeutic and outpatient activities, following the available institutional indications (Table 1 ). One of the most widely implemented strategies included the extensive use of hypofractionated regimens (92, 73.6%). This approach was most frequently adopted by large centres (>500 patients/year) compared to smaller institutions (75.9% vs 58.8%), regardless of their academic profile. Rescheduling of the patients waiting lists (prioritization) was also carried out in 78 facilities (62.4%) but did not affect first out-patient consultations, which continued to be ensured almost everywhere. On the other hand, virtually all responders had to cancel routine follow-up examinations and maintain only those with high priority (high risk of recurrence, acute RT-induced toxicity, etc.). To guarantee the continuity of care, in 78 centres (62.4%) telematic consultations were activated. Even though no centres closed, the emergency inevitably brought some repercussions on the overall clinical activity volumes of the interviewed centres (Fig. 1 d), as 38 (30.4%) reduced their workload by 10–30% and 11 (8.8%) by 30–50%.
Table 1

How COVID-19 outbreak has changed the clinical practice of Italian Radiation Oncology Departments.

Adopted measureNo. centres (%)(All centres: N = 125)
Out-patient visitsNo changes7 (5.6%)
Non-urgent follow-up visits cancelled115 (92.0%)
First visits cancelled2 (1.6%)
Telematic visits78 (62.4%)
RT treatmentsNo substantial changes20 (16.0%)
Pts treatment planning list rescheduling78 (62.4%)
Promoting home cures46 (36.8%)
Promoting short treatments / hypofractionation92 (73.6%)
Positive/suspected pts treated in dedicated time slots37 (29.6%)
Clinical activities (overall)No reduction35 (28.0%)
<10% reduction40 (32.0%)
10%–30% reduction38 (30.4%)
30%–50% reduction11 (8.8%)
50%–70% reduction1 (0.8%)
>70% reduction
Periodic controls on LINACsNo changes112 (89.6%)
Changes in daily controls8 (6.4%)
Changes in weekly controls5 (4.0%)
Changes in monthly controls4 (3.2%)
RT wards conversion*Yes6 (37.5%**)
No10 (62.5%**)
Responsible for outbreak management in the Radiation Oncology DepartmentRT director111 (88.8%)
RT task force20 (16.0%)
Health Directorate46 (36.8%)
Occupational medicine office or other bodies15 (12.0%)



PPEROs
RTTs & Ns
Others#
Surgical maskFFP2FFP3Disposable gownsOverhead capOvershoesGoggles or visorsGloves118 (94.4%)62 (49.6%)12 (9.6%)79 (63.2%)63 (50.4%)38 (30.4%)73 (60.0%)115 (92.0%)115 (92.0%)68 (54.4%)14 (11.2%)100 (80.0%)76 (60.8%)46 (36.8%)88 (70.4%)118 (94.4%)124 (99.2%)10 (8.0%)1 (0.8%)11 (8.8%)6 (4.8%)2 (1.6%)9 (7.2%)80 (64.0%)

List of abbreviations: DH: day hospital; FFP2, FFP3: protection class 2 and 3 filtering facepieces (FFPs); LINAC: linear accelerator; N: nurse; PPE: personal protective equipment; pt: patient; RO: radiation oncologist; RT: radiation therapy; RTT: RT technician.

RT wards/DHs converted into COVID-19 centres.

percentage refers to the number of centres equipped with RT in-patient wards or DHs.

personnel not in direct contact with patients. Most significant results are in bold.

Fig. 1

Total number of COVID-19 positive patients in the Radiation Oncology Departments (a), units of personnel in quarantine (any COVID-19 related absence from work) (b) units of personnel dedicated to COVID-19 emergency (outside Radiation Oncology Department) (c) and RT centres with more than 10% activity reduction (d) by region. NB: Light gray means no cases. In case 5 to 10 or more than 11 were selected, the lower limit of the interval was considered as actual number of cases, so the map underestimates the total number of cases. Fig. 1 has been created using Microsoft Excel Bing Maps, Bing © GeoNames, HERE, MSFT.

How COVID-19 outbreak has changed the clinical practice of Italian Radiation Oncology Departments. List of abbreviations: DH: day hospital; FFP2, FFP3: protection class 2 and 3 filtering facepieces (FFPs); LINAC: linear accelerator; N: nurse; PPE: personal protective equipment; pt: patient; RO: radiation oncologist; RT: radiation therapy; RTT: RT technician. RT wards/DHs converted into COVID-19 centres. percentage refers to the number of centres equipped with RT in-patient wards or DHs. personnel not in direct contact with patients. Most significant results are in bold. Total number of COVID-19 positive patients in the Radiation Oncology Departments (a), units of personnel in quarantine (any COVID-19 related absence from work) (b) units of personnel dedicated to COVID-19 emergency (outside Radiation Oncology Department) (c) and RT centres with more than 10% activity reduction (d) by region. NB: Light gray means no cases. In case 5 to 10 or more than 11 were selected, the lower limit of the interval was considered as actual number of cases, so the map underestimates the total number of cases. Fig. 1 has been created using Microsoft Excel Bing Maps, Bing © GeoNames, HERE, MSFT.

Management of patients and clinical practice

In order to limit the access of positive or suspect patients in the Radiation Oncology Departments, one to three levels of triage to check health status and suspect contacts were adopted. The first-line screening, consisting in phone interviews, was adopted in 61 centres (48.8%); the second-line control, consisting in a checkpoint at the main hospital entrance, was available in 68 facilities (54.4%) and was mainly carried out by nurses. Approximately 75% responders also opted for a further level of triage at the entrance of their Radiation Oncology Department. Regardless of the modality (telephonic or in situ), the triage procedures consisted mainly of interviews on symptoms, even if a significant proportion of centres also declared to ask about possible suspect contacts and to measure body temperature and oxygen saturation. The patients allowed to access the Radiation Oncology Department had to follow strict measures. Most patients were compelled to wear a surgical mask (123, 98.4%), to respect inter-personal distance measures (118, 94.4%) and could not be accompanied (95, 76%). Cleaning of rooms and surfaces was also a widely adopted countermeasure (106, 84.8%). Interestingly, 76 centres (62.3%) had no confirmed COVID-19 positive patients during ongoing treatment, and 32 centres (26.2%) had three or less. The majority of cases was reported in Lombardy and northern Italy in general (Fig. 1a). Positive patients were mostly affected by lung or head and neck cancers. In case of positive patients, approximately two out of three centres opted for suspending the treatment, while the remainder decided to safely continue the remaining RT sessions. In case of a positive patient, for whom the treatment was suspended, and who resulted negative after two consecutive swabs, about half centres stated they would start or continue the treatment immediately. Other responders were more cautious and would wait for additional 14 or even 30 days. Only a minority (five centres) declared their intention not to treat at all the COVID-19 positive patients with RT. Less than half responders had patients with documented contact with COVID-19 positive individuals and opinions were divided whether to treat this category of patients or not, with or without special precautions.

Management of personnel

In virtually all facilities, some basic protections, such as surgical masks and gloves, were provided indiscriminately to any type of personnel, while more sophisticated personal protective equipment (PPE), such as protection class 2 filtering facepieces (FFP2), was a prerogative of personnel in close contact with patients, such as physicians, nurses and RT technicians (Table 1). As far as meetings are concerned, only minorities decided to keep or, conversely, to cancel all of them indiscriminately (four, 3.2% vs 16, 12.8%, respectively) and about half responders opted for virtual solutions. To limit overcrowding, working from home solutions were permitted to a large proportion of personnel not in direct contact with patients (61 centres, 48.8%). Only few centres extended this modality also to sanitary staff (14, 11.2%), preferring turnover (64, 51.2%) or recovery of hours or holidays (44, 35.1%). Of note, in one centre, the risk of infection between operators and patients was reduced by defining two working teams who never meet each other and by extending the working time. These measures had some impact on the linac quality assurance procedures, as in 13 centres (10.4%) (10 treating less than 2000 patients/year and three more than 2000 patients/year) some changes occurred (Table 1). Forty-five per cent of centres had one or more staff persons in quarantine (any COVID-19 related absence), and 11 of them (8.8%) had more than five units off. The total number of units of personnel in quarantine reflects the number of reported cases of COVID-19 positive patients in the region (Fig. 1a/b). Physicians and RT technicians were most frequently infected, followed by nurses, medical physicists and other personnel. In 20 centres (16.0%), mostly located in Northern Italy (Fig. 1c), the medical staff was deployed elsewhere to cope with the emergency and dislocated either in COVID-19 wards, triage checkpoints, task forces or other Radiation Oncology Departments, requiring a daily effort in the large majority of cases. Considering the possible psychological and emotive repercussions brought by the emergency, in approximately half of the centres psychological support for personnel and/or staff was activated. As mentioned above, the AIRO community has quickly faced the emergency by producing a public guidance document for the Radiation Oncology Departments indicating how to manage the emergency. The utility of this document is confirmed by the fact that 116 centres (92.8%) consulted the document and found it useful.

Discussion and conclusion

The present study points out how the Italian Radiation Oncology Departments have rapidly and efficiently coped with the disruption brought by the COVID-19 pandemic. Overall, the results are in line with those previously observed in Lombardy [6], even if some differences exist. As expected, being Lombardy the region with the higher rate of infection, the proportion of centres reporting cases of positive patients was higher here compared to Italy as a whole (15/31, 48.4% vs 46/125, 36.8%). Nevertheless, despite the entity of the pandemic in Italy, the total number of positive patients and units of personnel in quarantine was relatively low. This fact can be ascribable to efficacy of triage procedures and, more in general, to all adopted measures. On the other hand, despite the reasonably higher probability of coming into contact with positive patients, the facilities in Lombardy had, on average, less PPE in use than the Italian average. As an example, FFP2 and FFP3 provision to personnel in contact with patients was approximately two and three times lower in Lombardy than the Italian average, respectively. This could be partly explained by the three-four weeks distance between the two surveys (the Lombardy and national surveys were performed at one and almost two months from the beginning of the outbreak, respectively). In fact, answers from facilities in Lombardy in this new survey are now aligned with the national trend, meaning that Italy as a country is moving in the right direction and PPE supply is improving. The increased awareness can be also due to the raising number of national and international guidelines, to the growing body of literature on the topic and to the detailed disease-oriented recommendations, as those available for prostate [12], lung [13], breast [14], head and neck [15], and haematological malignancies [16]. These documents generally support hypofractionated regimens and shorter schedules and advise to defer the non-urgent treatments. However, the choice of the most appropriate regimen is left to the treating physician on an individual basis, considering cancer-related and patient-related factors, clinical conditions, machine and staff availability and epidemiological situation of the area. Our study also showed that even though working from home solutions cannot entirely replace activities usually carried out in Radiation Oncology Departments, they could represent a valid tool for reducing contacts and for accomplishing office-based tasks, such as remote contouring and planning or scientific writing. Telephonic triage procedures tend to avoid healthcare staff to be in contact with potentially positive patients and the patient to undertake a useless travel if not allowed to enter the hospital. Moreover, telemedicine allows for more flexibility on the side of both the clinician and the patient, as consultations can easily be rescheduled, and meetings can be held from home. In general, the pandemic has demonstrated that information technologies should be more promoted independently from this specific context. In conclusion, our survey showed rapid reaction by the Radiation Oncology Departments to the COVID-19 crisis, demonstrating that use of information technologies, RT prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and safety while safeguarding the healthcare staff.

Conflict of interest statement

The authors have no affiliation with any organization with a direct or indirect financial interest in the subject matter discussed in the manuscript.
  13 in total

1.  Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016.

Authors:  Mauro F Palazzi; Carlo Soatti; Barbara A Jereczek-Fossa; Luigi F Cazzaniga; Paolo Antognoni; Gianstefano Gardani; Marcello Amadori; Ambrogia Baio; Giancarlo Beltramo; Mario Bignardi; Stefano Bracelli; Alberto Buffoli; Simona Castiglioni; Gianpiero Catalano; Nadia Di Muzio; Carlo Fallai; Laura Fariselli; Paolo Frata; Alberto Gramaglia; Corrado Italia; Giovanni Ivaldi; Fabrizio Lombardi; Stefano M Magrini; Simonetta Nava; Enrico Sarti; Luciano Scandolaro; Marta Scorsetti; Francesco Stiglich; Roberto Tortini; Riccardo Valdagni; Francesca Valvo; Vittorio Vavassori; Elena L Sbicego; Sandro Tonoli; Roberto Orecchia
Journal:  Tumori       Date:  2018-07-09       Impact factor: 2.098

Review 2.  Caring for patients with cancer in the COVID-19 era.

Authors:  Joris van de Haar; Louisa R Hoes; Charlotte E Coles; Kenneth Seamon; Stefan Fröhling; Dirk Jäger; Franco Valenza; Filippo de Braud; Luigi De Petris; Jonas Bergh; Ingemar Ernberg; Benjamin Besse; Fabrice Barlesi; Elena Garralda; Alejandro Piris-Giménez; Michael Baumann; Giovanni Apolone; Jean Charles Soria; Josep Tabernero; Carlos Caldas; Emile E Voest
Journal:  Nat Med       Date:  2020-04-16       Impact factor: 53.440

3.  ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic.

Authors:  Joachim Yahalom; Bouthaina Shbib Dabaja; Umberto Ricardi; Andrea Ng; N George Mikhaeel; Ivan R Vogelius; Tim Illidge; Shunan Qi; Andrew Wirth; Lena Specht
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

4.  COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy.

Authors:  B A Jereczek-Fossa; M F Palazzi; C P Soatti; L F Cazzaniga; G B Ivaldi; M Pepa; M Amadori; P Antognoni; S Arcangeli; A Buffoli; G Beltramo; S Berlinghieri; M Bignardi; S Bracelli; L Bruschieri; S Castiglioni; G Catalano; N Di Muzio; C Fallai; L Fariselli; A R Filippi; A Gramaglia; C Italia; F Lombardi; S M Magrini; S Nava; E Orlandi; N Pasinetti; E L Sbicego; L Scandolaro; M Scorsetti; F Stiglich; S Tonoli; R Tortini; R Valdagni; V Vavassori; G Marvaso
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-04-23       Impact factor: 4.126

5.  International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic.

Authors:  C E Coles; C Aristei; J Bliss; L Boersma; A M Brunt; S Chatterjee; G Hanna; R Jagsi; O Kaidar Person; A Kirby; I Mjaaland; I Meattini; A M Luis; G N Marta; B Offersen; P Poortmans; S Rivera
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-05       Impact factor: 4.126

6.  Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience.

Authors:  Marco Krengli; Eleonora Ferrara; Federico Mastroleo; Marco Brambilla; Umberto Ricardi
Journal:  Adv Radiat Oncol       Date:  2020-03-20

Review 7.  First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments.

Authors:  Stephanie E Combs; Claus Belka; Maximilian Niyazi; Stefanie Corradini; Steffi Pigorsch; Jan Wilkens; Anca L Grosu; Matthias Guckenberger; Ute Ganswindt; Denise Bernhardt
Journal:  Radiat Oncol       Date:  2020-04-07       Impact factor: 3.481

8.  Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19.

Authors:  Nicholas G Zaorsky; James B Yu; Sean M McBride; Robert T Dess; William C Jackson; Brandon A Mahal; Ronald Chen; Ananya Choudhury; Ann Henry; Isabel Syndikus; Timur Mitin; Alison Tree; Amar U Kishan; Daniel E Spratt
Journal:  Adv Radiat Oncol       Date:  2020-04-01

9.  Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.

Authors:  David J Thomson; David Palma; Matthias Guckenberger; Panagiotis Balermpas; Jonathan J Beitler; Pierre Blanchard; David Brizel; Wilfred Budach; Jimmy Caudell; June Corry; Renzo Corvo; Mererid Evans; Adam S Garden; Jordi Giralt; Vincent Gregoire; Paul M Harari; Kevin Harrington; Ying J Hitchcock; Jorgen Johansen; Johannes Kaanders; Shlomo Koyfman; J A Langendijk; Quynh-Thu Le; Nancy Lee; Danielle Margalit; Michelle Mierzwa; Sandro Porceddu; Yoke Lim Soong; Ying Sun; Juliette Thariat; John Waldron; Sue S Yom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-14       Impact factor: 7.038

10.  Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists.

Authors:  Icro Meattini; Pierfrancesco Franco; Liliana Belgioia; Luca Boldrini; Angela Botticella; Maria Carmen De Santis; Giulia Marvaso; Giampaolo Montesi; Silvana Parisi; Luca Triggiani; Matteo Lambertini; Lorenzo Livi
Journal:  ESMO Open       Date:  2020-04
View more
  24 in total

Review 1.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

2.  A small case series about safety and effectiveness of a hypofractionated electron beam radiotherapy schedule in five fractions for facial non melanoma skin cancer among frail and elderly patients.

Authors:  Gianluca Ferini; Laura Molino; Laura Bottalico; Paolino De Lucia; Francesco Garofalo
Journal:  Rep Pract Oncol Radiother       Date:  2021-02-25

Review 3.  Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology).

Authors:  Isabella Palumbo; Simona Borghesi; Fabiana Gregucci; Sara Falivene; Antonella Fontana; Cynthia Aristei; Antonella Ciabattoni
Journal:  J Geriatr Oncol       Date:  2021-05-18       Impact factor: 3.599

4.  Impact of COVID-19 on cancer care in India: a cohort study.

Authors:  Priya Ranganathan; Manju Sengar; Girish Chinnaswamy; Gaurav Agrawal; Rajkumar Arumugham; Rajiv Bhatt; Ramesh Bilimagga; Jayanta Chakrabarti; Arun Chandrasekharan; Harit Kumar Chaturvedi; Rajiv Choudhrie; Mitali Dandekar; Ashok Das; Vineeta Goel; Caleb Harris; Sujai Kolnadguthu Hegde; Narendra Hulikal; Deepa Joseph; Rajesh Kantharia; Azizullah Khan; Rohan Kharde; Navin Khattry; Maqbool M Lone; Umesh Mahantshetty; Hemant Malhotra; Hari Menon; Deepti Mishra; Rekha A Nair; Shashank J Pandya; Nidhi Patni; Jeremy Pautu; Simon Pavamani; Satyajit Pradhan; Subramanyeshwar Rao Thammineedi; G Selvaluxmy; Krishna Sharan; B K Sharma; Jayesh Sharma; Suresh Singh; Gowtham Chandra Srungavarapu; R Subramaniam; Rajendra Toprani; Ramanan Venkat Raman; Rajendra Achyut Badwe; C S Pramesh
Journal:  Lancet Oncol       Date:  2021-05-27       Impact factor: 41.316

5.  Letter to the editor regarding Wei W et al.: "Experience of the Hubei cancer hospital in Wuhan, China".

Authors:  Anna Merlotti; Riccardo Vigna Taglianti; Antonella Melano; Luca Gianello; Alessia Reali; Rachele Petrucci; Elvio Grazioso Russi
Journal:  Radiother Oncol       Date:  2020-07-01       Impact factor: 6.280

6.  COVID-19 and information and communication technology in radiation oncology: A new paradigm.

Authors:  Castalia Fernández; Virginia Ruiz; Felipe Couñago
Journal:  World J Clin Oncol       Date:  2020-12-24

7.  Professional practice changes in radiotherapy physics during the COVID-19 pandemic.

Authors:  Jenny Bertholet; Marianne C Aznar; Cristina Garibaldi; David Thwaites; Eduard Gershkevitsh; Daniela Thorwarth; Dirk Verellen; Ben Heijmen; Coen Hurkmans; Ludvig Muren; Kathrine Røe Redalen; Frank-André Siebert; Marco Schwarz; Wouter Van Elmpt; Dietmar Georg; Nuria Jornet; Catharine H Clark
Journal:  Phys Imaging Radiat Oncol       Date:  2021-06-22

8.  How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.

Authors:  Giulia Pasello; Jessica Menis; Sara Pilotto; Stefano Frega; Lorenzo Belluomini; Federica Pezzuto; Anna Caliò; Matteo Sepulcri; Nunzia Luna Valentina Cernusco; Marco Schiavon; Maurizio Valentino Infante; Marco Damin; Claudio Micheletto; Paola Del Bianco; Riccardo Giovannetti; Laura Bonanno; Umberto Fantoni; Valentina Guarneri; Fiorella Calabrese; Federico Rea; Michele Milella; PierFranco Conte
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

9.  The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care.

Authors:  Giuseppe Carlo Iorio; Umberto Ricardi; Pierfrancesco Franco
Journal:  Radiother Oncol       Date:  2020-07-13       Impact factor: 6.280

10.  Two months of radiation oncology in the heart of Italian "red zone" during COVID-19 pandemic: paving a safe path over thin ice.

Authors:  Michela Buglione; Luigi Spiazzi; Andrea Emanuele Guerini; Fernando Barbera; Nadia Pasinetti; Ludovica Pegurri; Luca Triggiani; Davide Tomasini; Diana Greco; Gianluca Costantino; Alessandra Bragaglio; Nadia Bonometti; Mara Liccioli; Lorella Mascaro; Filippo Alongi; Stefano Maria Magrini
Journal:  Radiat Oncol       Date:  2020-08-10       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.